> top > docs > PubMed:32284362 > annotations

PubMed:32284362 JSONTXT

Annnotations TAB JSON ListView MergeView

LitCovid-OGER-BB

Id Subject Object Predicate Lexical cue
T1 0-8 SP_7 denotes COVID-19
T2 42-53 NCBITaxon:11118 denotes coronavirus
T3 60-68 SP_7 denotes COVID-19
T4 412-420 SP_7 denotes COVID-19
T5 455-463 SP_7 denotes COVID-19
T6 561-578 CHEBI:35705 denotes immunosuppressive
T7 561-578 CHEBI:35705 denotes immunosuppressive
T8 1009-1017 SP_7 denotes COVID-19

LitCovid-PD-MONDO

Id Subject Object Predicate Lexical cue mondo_id
T1 0-8 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T2 60-68 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T3 412-420 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T4 455-463 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096
T5 507-528 Disease denotes neuromuscular disease http://purl.obolibrary.org/obo/MONDO_0019056
T6 1009-1017 Disease denotes COVID-19 http://purl.obolibrary.org/obo/MONDO_0100096

LitCovid-PD-CLO

Id Subject Object Predicate Lexical cue
T1 79-82 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T2 177-178 http://purl.obolibrary.org/obo/CLO_0001020 denotes a
T3 204-207 http://purl.obolibrary.org/obo/CLO_0051582 denotes has
T4 339-344 http://purl.obolibrary.org/obo/UBERON_0007688 denotes field

LitCovid-sentences

Id Subject Object Predicate Lexical cue
T1 0-37 Sentence denotes COVID-19 and neuromuscular disorders.
T2 38-173 Sentence denotes The coronavirus 2019 (COVID-19) pandemic has potential to disproportionately and severely affect patients with neuromuscular disorders.
T3 174-345 Sentence denotes In a short period of time, it has already caused reorganization of neuromuscular clinical care delivery and education, which will likely have lasting effects on the field.
T4 346-743 Sentence denotes This article reviews (1) potential neuromuscular complications of COVID-19, (2) assessment and mitigation of COVID-19-related risk for patients with preexisting neuromuscular disease, (3) guidance for management of immunosuppressive and immunomodulatory therapies, (4) practical guidance regarding neuromuscular care delivery, telemedicine, and education, and (5) effect on neuromuscular research.
T5 744-860 Sentence denotes We outline key unanswered clinical questions and highlight the need for team-based and interspecialty collaboration.
T6 861-1060 Sentence denotes Primary goals of clinical research during this time are to develop evidence-based best practices and to minimize morbidity and mortality related to COVID-19 for patients with neuromuscular disorders.

LitCovid-PubTator

Id Subject Object Predicate Lexical cue tao:has_database_id
2 0-8 Disease denotes COVID-19 MESH:C000657245
3 13-36 Disease denotes neuromuscular disorders MESH:D009468
16 42-58 Species denotes coronavirus 2019 Tax:2697049
17 60-68 Disease denotes COVID-19 MESH:C000657245
18 135-143 Species denotes patients Tax:9606
19 149-172 Disease denotes neuromuscular disorders MESH:D009468
20 412-420 Disease denotes COVID-19 MESH:C000657245
21 455-463 Disease denotes COVID-19 MESH:C000657245
22 481-489 Species denotes patients Tax:9606
23 507-528 Disease denotes neuromuscular disease MESH:D009468
24 988-997 Disease denotes mortality MESH:D003643
25 1009-1017 Disease denotes COVID-19 MESH:C000657245
26 1022-1030 Species denotes patients Tax:9606
27 1036-1059 Disease denotes neuromuscular disorders MESH:D009468